Search results for "Glycerides"

showing 10 items of 343 documents

Partition of oleic acid between the lymph and portal blood in rats having a diverted bile–pancreatic duct

1996

AbstractThe present study examines the suggestion that in the absence of adequate bile and pancreatic juice, which support the absorption from the gut of long-chain fatty acidsinto lymph, the fatty acids are absorbed directly into the portal blood. Oleic acid (18:l) partitioning between lymph and portal blood was investigated in intact and bile- and pancreatic juice-diverted rats. In a first set of experiments, 18: 1 absorption from the gut into lymph and blood was studied by continuous recovery of the mesenteric lymph for 6 h and mesenteric portal venous blood for 1 h. In a second set of experiments, esterification processes were investigated by study of the mucosal distribution of labelle…

Malemedicine.medical_specialtyTime FactorsMedicine (miscellaneous)Oleic AcidsAbsorption (skin)GlyceridesDiglycerideschemistry.chemical_compoundPancreatic JuiceInternal medicinemedicineAnimalsBileIntestinal MucosaRats WistarPancreatic ductNutrition and DieteticsVenous bloodRatsOleic acidmedicine.anatomical_structureEndocrinologyIntestinal AbsorptionchemistryAcyltransferasePancreatic juiceLymphLymphDigestionLiver CirculationBritish Journal of Nutrition
researchProduct

Comparative effects of rosiglitazone and pioglitazone on fasting and postprandial low-density lipoprotein size and subclasses in patients with Type 2…

2008

To assess the effects of pioglitazone and rosiglitazone on fasting and postprandial low-density lipoprotein (LDL) size and subclasses in patients with Type 2 diabetes.Nine Type 2 diabetic patients (age 61 +/- 10 years, body mass index 30 +/- 5 kg/m(2), glycosylated hemoglobin [HbA1c] 7.5 +/- 0.5%) were randomized in a crossover trial to rosiglitazone 4 mg b.i.d. or pioglitazone 45 mg/day for 12 weeks with an 8-week wash-out period. LDL size and subclasses were determined by non-denaturing polyacrylamide gradient gel electrophoresis. A standardized breakfast was served and variables were assessed after 3 and 6 h.HbA1c, insulin sensitivity (as assessed by the homeostasis model assessment) and…

Malemedicine.medical_specialtyType 2 diabetesRosiglitazonechemistry.chemical_compoundDiabetes mellitusInternal medicinemedicineHumansHypoglycemic AgentsPharmacology (medical)Prospective StudiesTriglyceridesPharmacologyGlycated HemoglobinCross-Over StudiesTriglyceridePioglitazoneCholesterolbusiness.industryGeneral MedicineCholesterol LDLFastingGlucose Tolerance TestMiddle Agedmedicine.diseasePostprandial PeriodLipoproteins LDLPostprandialEndocrinologychemistryDiabetes Mellitus Type 2Low-density lipoproteindense LDL diabetes LDL size pioglitazone postprandial rosiglitazoneElectrophoresis Polyacrylamide GelFemaleThiazolidinedionesbusinessRosiglitazonePioglitazonemedicine.drug
researchProduct

Reduction in systemic and VLDL triacylglycerol concentration after a 3-month Mediterranean-style diet in high-cardiovascular-risk subjects.

2010

The first results of the PREDIMED (PREvencion con Dieta MEDiterranea) randomized trial, after 3-month intervention, showed that the Mediterranean Diet (MD), supplemented with either virgin olive oil (VOO) or nuts, reduced systolic blood pressure, serum cholesterol and triacylglycerol (TG) concentrations and increased high-density lipoprotein (HDL)-cholesterol when compared to a control (low-fat diet) group. Serum TG levels are an independent risk factor for coronary heart disease and are strongly determined by very low-density lipoprotein (VLDL) composition, which can be specifically modified by dietary lipid source. Within the context of the PREDIMED study, we assessed the VLDL composition…

Malemedicine.medical_specialtyVery low-density lipoproteinMediterranean dietEndocrinology Diabetes and MetabolismLinoleic acidClinical BiochemistryDietary lipidContext (language use)BiologyLipoproteins VLDLDiet MediterraneanTriacylglycerolBiochemistrychemistry.chemical_compoundBlood serumRisk FactorsMediterranean dietInternal medicineVirgin olive oilmedicineHumansNutsPlant OilsMolecular BiologyOlive OilTriglyceridesAgedNutrition and DieteticsCholesterolMiddle AgedDietary FatsEndocrinologychemistryCardiovascular Diseaseslipids (amino acids peptides and proteins)FemaleVLDLLipoproteinThe Journal of nutritional biochemistry
researchProduct

Dietary protein deficiency affects n-3 and n-6 polyunsaturated fatty acids hepatic storage and very low density lipoprotein transport in rats on diff…

1994

Fatty livers and the similarity between the skin lesions in kwashiorkor and those described in experimental essential fatty acid (EFA) deficiency have led to the hypothesis that protein and EFA deficiencies may both occur in chronic malnutrition. The relationship between serum very low density lipoprotein (VLDL) and hepatic lipid composition was studied after 28 d of protein depletion to determine the interactions between dietary protein levels and EFA availability. Rats were fed purified diets containing 20 or 2% casein and 5% fat as either soybean oil rich in EFA, or salmon oil rich in eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids, or hydrogenated coconut, oil poor in EFA. Animal…

Malemedicine.medical_specialtyVery low-density lipoproteinfood.ingredientLow proteinDocosahexaenoic AcidsBiologyLipoproteins VLDLBiochemistrySoybean oilchemistry.chemical_compoundfoodEssential fatty acidInternal medicineCaseinFatty Acids Omega-6Protein DeficiencyFatty Acids Omega-3medicineAnimalsFood scienceRats WistarPhospholipidsTriglycerideschemistry.chemical_classificationFatty Acids EssentialOrganic Chemistryfood and beveragesFatty acidBiological TransportCell BiologyDietary FatsDietRatsEndocrinologychemistryEicosapentaenoic AcidLiverFatty Acids Unsaturatedlipids (amino acids peptides and proteins)Arachidonic acidDietary ProteinsPolyunsaturated fatty acidLipids
researchProduct

White fish reduces cardiovascular risk factors in patients with metabolic syndrome: the WISH-CARE study, a multicenter randomized clinical trial.

2013

Reduction of cardiovascular risk with high consumption of fish in diet is still a matter of debate, and concerns about heavy metal contamination have limited consumption of oily fish. We aimed to evaluate the effect of regular ingestion of white fish on cardiovascular risk factors in patients with metabolic syndrome.Multicenter randomized crossover clinical trial including 273 individuals with metabolic syndrome. An 8-week only-one dietary intervention: 100 g/d of white fish (Namibia hake) with advice on a healthy diet, compared with no fish or seafood with advice on a healthy diet. Outcomes were lipid profile, individual components of the metabolic syndrome, serum insulin concentrations, h…

Malemedicine.medical_specialtyWaistMeatEndocrinology Diabetes and MetabolismMedicine (miscellaneous)PhysiologyBlood Pressurelaw.inventionBody Mass Indexchemistry.chemical_compoundInsulin resistanceRandomized controlled triallawRisk FactorsInternal medicinemedicineOily fishAnimalsHumansInsulinTriglyceridesAgedMetabolic SyndromeNutrition and DieteticsTriglyceridemedicine.diagnostic_testbusiness.industryCholesterol HDLFatty AcidsFishesCholesterol LDLMiddle Agedmedicine.diseaseDietBlood pressureEndocrinologyC-Reactive ProteinTreatment OutcomechemistrySeafoodCardiovascular DiseasesFemaleMetabolic syndromeInsulin ResistanceWaist CircumferenceCardiology and Cardiovascular MedicineLipid profilebusinessNutrition, metabolism, and cardiovascular diseases : NMCD
researchProduct

Differences in clinical and biological characteristics and prevalence of chronic complications related to aging in patients with type 2 diabetes

2015

Type 2 diabetes mellitus (T2DM) is a chronic, highly prevalent disease that increases with age. Because of this, and due to its chronic complications, T2DM causes high human, social, and financial costs. In addition, the elderly population with T2DM has a marked clinical heterogeneity. Therefore, our main objective was to analyze the relationship of age with the clinical and biological manifestations of the disease and the prevalence of chronic complications in patients with T2DM.A cross-sectional study of a large population with T2DM (n=405) randomly selected from a Diabetes Unit and 2 health care centers (60%). The clinical, anthropometric, and biochemical variables of the subjects were c…

Malemedicine.medical_specialtyendocrine system diseasesCross-sectional studyBlood Pressure030209 endocrinology & metabolismDiseaseType 2 diabetes03 medical and health sciences0302 clinical medicineDiabetes mellitusInternal medicinePrevalencemedicineHumans030212 general & internal medicineTriglyceridesAgedMetabolic Syndromebusiness.industryAge Factorsnutritional and metabolic diseasesType 2 Diabetes MellitusMiddle Agedmedicine.diseaseSurgeryCross-Sectional StudiesDiabetes Mellitus Type 2FemaleWaist CircumferenceMetabolic syndromebusinessPolyneuropathyKidney diseaseEndocrinología y Nutrición (English Edition)
researchProduct

Portulaca oleracea reduces triglyceridemia, cholesterolemia, and improves lecithin: cholesterol acyltransferase activity in rats fed enriched-cholest…

2014

Abstract Purpose The effects of Portulaca oleracea ( Po ) lyophilized aqueous extract were determined on the serum high-density lipoproteins (HDL 2 and HDL 3 ) amounts and composition, as well as on lecithin: cholesterol acyltansferase (LCAT) activity. Methods Male Wistar rats ( n  = 12) were fed on 1% cholesterol-enriched diet for 10 days. After this phase, hypercholesterolemic rats (HC) were divided into two groups fed the same diet supplemented or not with Portulaca oleracea ( Po -HC) (0.5%) for four weeks. Results Serum total cholesterol (TC) and triacylglycerols (TG), and liver TG values were respectively 1.6-, 1.8-, and 1.6-fold lower in Po -HC than in HC group. Cholesterol concentrat…

Malemedicine.medical_specialtyfood.ingredientHypercholesterolemiaPharmaceutical SciencePortulacaPortulacaLecithinCholesterol DietaryPhosphatidylcholine-Sterol O-Acyltransferasechemistry.chemical_compoundfoodInternal medicineDrug DiscoverymedicineAnimalsRats WistarTriglyceridesHypolipidemic AgentsPharmacologychemistry.chemical_classificationHypertriglyceridemiaChromatographybiologyCholesterolPlant ExtractsReverse cholesterol transportbiology.organism_classificationPlant LeavesEnzymeEndocrinologyCholesterolComplementary and alternative medicinechemistryLiverLecithin—cholesterol acyltransferasebiology.proteinMolecular Medicinelipids (amino acids peptides and proteins)Composition (visual arts)Acyl groupPhytomedicine : international journal of phytotherapy and phytopharmacology
researchProduct

Cacao extract enriched in polyphenols prevents endocrine-metabolic disturbances in a rat model of prediabetes triggered by a sucrose rich diet.

2019

Cocoa extracts rich in polyphenols are used as potential agent for treating diabetes. Cocoa polyphenols have been proved to ameliorate important hallmarks of type-2 diabetes (T2D). They can regulate glucose levels by increasing insulin secretion, promoting β-cell proliferation and a reduction of insulin resistance. In addition, epidemiological evidence indicates that consumption of flavonoid decreases the incidence of T2D.T2D is preceded by a prediabetic state in which the endocrine-metabolic changes described in T2D are already present. Since epidemiological evidence indicates that consumption of flavonoid decreases its incidence, we evaluated possible preventive effects of polyphenol-enri…

Malemedicine.medical_specialtymedicine.disease_causePrediabetic State03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInsulin resistanceDietary SucroseInternal medicineDiabetes mellitusDrug DiscoverymedicineAnimalsHumansPrediabetesTriglycerides030304 developmental biologyPharmacology0303 health sciencesCacaoGlycogenPlant ExtractsCocoa ExtractHypertriglyceridemiafood and beveragesPolyphenolsGlutathionemedicine.diseaseRatsDisease Models AnimalOxidative StressEndocrinologychemistryDiabetes Mellitus Type 2Liver030220 oncology & carcinogenesisInsulin ResistanceOxidative stressJournal of ethnopharmacology
researchProduct

Improvement of fibrinolysis and plasma lipoprotein levels induced by gemfibrozil in hypertriglyceridemia.

1995

A randomized double-blind study was carried out with gemfibrozil (600 mg b.i.d.) vs placebo in 20 patients (twelve males and eight females, age 52 +/- 3 years, BMI 24.2 +/- 0.4) suffering from primary hypertriglyceridemia (Fredrickson's type IV). Each group was treated for a 12 week period with gemfibrozil (n = 10) or placebo (n = 10) patients) in a double-blind fashion. Total cholesterol, HDL-cholesterol (HDL-C) and its subfractions (HDL2-C and HDL3-C), blood glucose, Apolipoproteins A1 and B, fibrinogen, plasminogen, factor VII, t-PA:Ag and PAI activity pre- and post-venous occlusion (VO) were determined. In the gemfibrozil-treated group a significant decrease of total cholesterol and tri…

Malemedicine.medical_specialtymedicine.medical_treatmentLipoproteinsFibrinogenchemistry.chemical_compoundDouble-Blind MethodInternal medicineFibrinolysismedicineGemfibrozilHumansTriglyceridesApolipoproteins BHypertriglyceridemiaTriglycerideApolipoprotein A-Ibusiness.industryCholesterolFibrinolysisHypertriglyceridemiaReverse cholesterol transportCholesterol HDLFibrinogenPlasminogenHematologyGeneral MedicineFactor VIIMiddle Agedmedicine.diseaseEndocrinologyCholesterolchemistryTissue Plasminogen Activatorlipids (amino acids peptides and proteins)FemaleGemfibrozilbusinessLipoproteinmedicine.drugBlood coagulationfibrinolysis : an international journal in haemostasis and thrombosis
researchProduct

Obstructive sleep apnoea independently predicts lipid levels: Data from the European Sleep Apnea Database

2018

Background and objective: Obstructive sleep apnoea (OSA) and dyslipidaemia are independent risk factors for cardiovascular disease. This study investigates the association between OSA and plasma lipid concentrations in patients enrolled in the European Sleep Apnea Database (ESADA) cohort. Methods: The cross-sectional analysis included 8592 patients without physician-diagnosed hyperlipidaemia or reported intake of a lipid-lowering drug (age 50.1 ± 12.7 years, 69.1% male, BMI: 30.8 ± 6.6 kg/m2, mean apnoea–hypopnoea index (AHI): 25.7 ± 25.9 events/h). The independent relationship between measures of OSA (AHI, oxygen desaturation index (ODI), mean and lowest oxygen saturation) and lipid profil…

MaleobesityDatabases Factualcholesterol dyslipidemia hypoxia obesity sleep apnoeaGastroenterologyCohort Studieschemistry.chemical_compound0302 clinical medicineRisk FactorsHypolipidemic AgentsOxygen saturation (medicine)Sleep Apnea Obstructivemedicine.diagnostic_testSleep apneaMiddle AgedEuropeQuartileCardiovascular DiseasesCohortFemalelipids (amino acids peptides and proteins)AdultPulmonary and Respiratory Medicinemedicine.medical_specialtySettore MED/10 - Malattie Dell'Apparato Respiratorio03 medical and health sciencesInternal medicinemedicineHumansTriglyceridesDyslipidemiashypoxiaCholesterolbusiness.industryCholesterol HDLdyslipidemiacholesterolCholesterol LDLta3121medicine.diseaseObesitynervous system diseasesrespiratory tract diseasesCross-Sectional Studies030228 respiratory systemchemistryLipid profilebusinesssleep apnoea030217 neurology & neurosurgeryDyslipidemiaRespirology
researchProduct